ProPhase Labs, Inc. PRPH
0.01 USD 0.00 (-3.33%)
Nov 4, 2026, 1:53 PM EST
0.0058 Day range 0.0058
0.0058 52-week range 3.20
- YTD
- -98.71%
- 1 year
- -99.82%
News
defenseworld.net Comparing ProPhase Labs (NASDAQ:PRPH) and Aurora Cannabis (NASDAQ:ACB) ProPhase Labs (NASDAQ: PRPH - Get Free Report) and Aurora Cannabis (NASDAQ: ACB - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two…
defenseworld.net Critical Contrast: ProPhase Labs (NASDAQ:PRPH) & Takeda Pharmaceutical (NYSE:TAK) Takeda Pharmaceutical (NYSE: TAK - Get Free Report) and ProPhase Labs (NASDAQ: PRPH - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two…
benzinga.com ProPhase Labs Q2 EPS $(0.22) Up From $(1.08) YoY, Sales $1.011M Down From $1.247M YoY ProPhase Labs (OTC:PRPH) reported quarterly losses of $(0.22) per share. This is a 79.63 percent increase over losses of $(1.08) per share from the same period last year. The company reported $1.011…
benzinga.com ProPhase Labs Q1 EPS $(0.43) Up From $(1.33) YoY, Sales $478.000K Down From $1.431M YoY ProPhase Labs (OTC:PRPH) reported quarterly losses of $(0.43) per share. This is a 67.67 percent increase over losses of $(1.33) per share from the same period last year. The company reported…
defenseworld.net ProPhase Labs (NASDAQ:PRPH) Shares Pass Below 200 Day Moving Average – What’s Next? ProPhase Labs, Inc. (NASDAQ: PRPH - Get Free Report) shares passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $1.24 and traded as low as…
defenseworld.net ProPhase Labs (NASDAQ:PRPH) Stock Crosses Below 200 Day Moving Average – What’s Next? ProPhase Labs, Inc. (NASDAQ: PRPH - Get Free Report)'s stock price passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $1.42 and traded as…
globenewswire.com ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform $201.2 Million in Gross Claims with Expanding Settlement Activity Across Multiple Insurance Carriers Active Negotiations Support Estimated $50–$60 Million Net Recovery and Near-Term Cash Flow…
defenseworld.net ProPhase Labs (NASDAQ:PRPH) Shares Pass Below 200 Day Moving Average – Time to Sell? Shares of ProPhase Labs, Inc. (NASDAQ: PRPH - Get Free Report) crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $1.86 and traded as low…
globenewswire.com ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity Institutional Financing Interest Emerges for Receivables-Backed Financing Following Extensive Diligence UNIONDALE, NY, March 17, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) ("ProPhase"…
globenewswire.com ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company's Balance Sheet UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH)…
globenewswire.com ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture UNIONDALE, NY, Jan. 26, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics and consumer products company, today provided an…
defenseworld.net ProPhase Labs (NASDAQ:PRPH) Stock Price Crosses Below Two Hundred Day Moving Average – Should You Sell? ProPhase Labs, Inc. (NASDAQ: PRPH - Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $3.12 and traded as low as…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
defenseworld.net ProPhase Labs (NASDAQ:PRPH) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? ProPhase Labs, Inc. (NASDAQ: PRPH - Get Free Report) shares passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $3.26 and traded as low as…
benzinga.com ProPhase Labs Says Stock Volatility Tied to Debt Conversions, Not Business Fundamentals ProPhase Labs, Inc. (OTC:PRPH) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company's underlying asset base.The Company believes that…
globenewswire.com ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value UNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company's…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
defenseworld.net Head to Head Contrast: Hikma Pharmaceuticals (OTCMKTS:HKMPF) vs. ProPhase Labs (NASDAQ:PRPH) ProPhase Labs (NASDAQ: PRPH - Get Free Report) and Hikma Pharmaceuticals (OTCMKTS:HKMPF - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results 
globenewswire.com ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com ProPhase Labs Approves 1-For-10 Reverse Stock Split, Effective December 22, 2025 On November 30, 2025, the Company's stockholders approved an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock at a ratio of one…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
defenseworld.net ProPhase Labs (NASDAQ:PRPH) versus Grifols (NASDAQ:GRFS) Head to Head Survey Grifols (NASDAQ: GRFS - Get Free Report) and ProPhase Labs (NASDAQ: PRPH - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on…
seekingalpha.com ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket 
benzinga.com ALT5 Sigma Announces Executive Changes, Jonathan Hugh CFO And Acting CEO To Depart, Without Cause; COO Ron Pitters Announces Departure; Tony Isaac Named Acting CEO, Steven Plumb Appointed CFO Departure of Chief Financial Officer and Acting Chief Executive Officer Effective November 21, 2025, the Board of Directors (the "Board") of the ALT5 Sigma Corporation (the "Company") determined to…
globenewswire.com Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1 UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. The exclusive event, hosted by…- benzinga.com ProPhase Labs Says On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease; Under Avtech's Updated Payment Schedule, Co To Make Weekly Payments Beginning Nov 28, Until Outstanding Past-Due Amounts Are Current On November 21, 2025, ProPhase Labs, Inc. (the "Company") received written confirmation from Avtech Capital, LLC ("Avtech") agreeing to continue its forbearance under the Company's existing equipment…
- benzinga.com ProPhase Labs Says Aware That Civil Action Pending In The U.S. District Court For The Eastern District Of New York Has Been Unsealed; Denies Wrongdoing, Maintains That Its Laboratory And Diagnostic Operations Follow Compliance Standards; Expects No Impact On Operations From Unsealed Matter; Co To Vigorously Defend Matter Once Formally Served On November 21, 2025, ProPhase Labs, Inc. (the "Company") became aware that a previously sealed civil action styled United States of America, State of New York, and State of New Jersey ex rel.…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
seekingalpha.com ProPhase Labs, Inc. (PRPH) Q3 2025 Earnings Call Transcript ProPhase Labs, Inc. ( PRPH ) Q3 2025 Earnings Call November 19, 2025 2:00 PM EST Company Participants Ted Karkus - Chairman & CEO Presentation Operator Hello, and good afternoon, everyone. Welcome to…- benzinga.com ProPhase Labs Is In Discussions For Strategic Initiative To Realize Significant Underlying Value In The Company; Announced It Is In M&A Related Discussions Not Connected To A Crypto Treasury Strategy ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important.Crown Medical Achieves Final Hurdle.…
- benzinga.com ProPhase Labs Q3 EPS $(0.16) Misses $(0.11) Estimate, Sales $883.000K Miss $5.690M Estimate ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 54.29 percent increase over losses of…
globenewswire.com ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important.
benzinga.com Earnings Scheduled For November 19, 2025 
benzinga.com A Peek at ProPhase Labs's Future Earnings 
globenewswire.com ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Prophase Labs Announces Publication Of Peer-Reviewed Study In Clinical And Translational Gastroenterology Conducted With The Mayo Clinic, Showing 100% Sensitivity And Strong Predictive Accuracy For Progression To Esophageal Cancer Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer ProgressionEarly Access Programs and Physician…